Corvus Pharmaceuticals, Inc. (CRVS) NASDAQ
14.69
+0.26(+1.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.69
+0.26(+1.80%)
Currency In USD
| Market Cap | 608.03M |
| Enterprise Value | 604.39M |
| P/E Ratio | -75.9 |
| PEG Ratio | -0.76 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 18.95 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -28.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.21 |
| Return On Equity | -0.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -105,000 |
| EBITDA | -42.97M |
| Net Income | -15.28M |
| Diluted EPS | -0.53 |
| Total Cash | 56.75M |
| Total Cash/Share | 0.72 |
| Total Debt | 937,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 6.21 |
| Book Value Per Share | 0.78 |
| 52-Week Change | 391.3 |
| 52-Week High | 26.95 |
| 52-Week Low | 2.54 |
| Moving Average 50 Days | 17.64 |
| Moving Average 200 Days | 9.35 |
| Average Volume | 3.42M |
| Shares Outstanding | 83.99M |
| % Held by Institutions | 56.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |